Discover 419 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 419
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Lexington KY, Cincinnati OH, West Chester OH,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Lexington KY, Indianapolis IN, Columbus OH,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
2024 Tirzepatide-Bariatric Surgery
for
Obesity and Obesity-related Medical Conditions,
Location: Lexington KY
Sponsor: Marlene Starr
Sex: All
Age: 18+
Code: NCT06721507
Recruiting
US National OCS Heart Perfusion (OHP) Registry
for
Heart Transplant
Location: Lexington KY, Cincinnati OH, Charlotte NC, Atlanta GA,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05915299
Recruiting
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
for
Endometrial Cancer
Location: Lexington KY
Sponsor: Rachel Miller
Sex: Female
Age: 18+
Code: NCT06677112
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Lexington KY, Cincinnati OH, Dayton OH, Indianapolis IN,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for
Invasive Mold Infections
Location: Lexington KY, Ann Arbor MI, Chicago IL, St Louis MO,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT06925321
Phase3, Recruiting
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy